379 related articles for article (PubMed ID: 21090937)
1. Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets.
Cole JE; Mitra AT; Monaco C
Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1619-35. PubMed ID: 21090937
[TBL] [Abstract][Full Text] [Related]
2. TLRs are important inflammatory factors in atherosclerosis and may be a therapeutic target.
Liu Y; Yu H; Zhang Y; Zhao Y
Med Hypotheses; 2008; 70(2):314-6. PubMed ID: 17689203
[TBL] [Abstract][Full Text] [Related]
3. Innate immune signals in atherosclerosis.
Lundberg AM; Hansson GK
Clin Immunol; 2010 Jan; 134(1):5-24. PubMed ID: 19740706
[TBL] [Abstract][Full Text] [Related]
4. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
Loppnow H; Werdan K; Buerke M
Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
[TBL] [Abstract][Full Text] [Related]
5. Essential Roles of Toll-Like Receptors in Atherosclerosis.
Lin J; Kakkar V; Lu X
Curr Med Chem; 2016; 23(5):431-54. PubMed ID: 26639096
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptors as targets for immune disorders.
Keogh B; Parker AE
Trends Pharmacol Sci; 2011 Jul; 32(7):435-42. PubMed ID: 21529972
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
Fukata M; Vamadevan AS; Abreu MT
Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of disease: Toll-like receptors in cardiovascular disease.
Frantz S; Ertl G; Bauersachs J
Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):444-54. PubMed ID: 17653117
[TBL] [Abstract][Full Text] [Related]
9. Endogenous inflammatory molecules engage Toll-like receptors in cardiovascular disease.
Ionita MG; Arslan F; de Kleijn DP; Pasterkamp G
J Innate Immun; 2010; 2(4):307-15. PubMed ID: 20431283
[TBL] [Abstract][Full Text] [Related]
10. Role of inflammatory cells and toll-like receptors in atherosclerosis.
Seneviratne AN; Monaco C
Curr Vasc Pharmacol; 2015; 13(2):146-60. PubMed ID: 24188491
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptors in inflammation of the central nervous system.
Kong Y; Le Y
Int Immunopharmacol; 2011 Oct; 11(10):1407-14. PubMed ID: 21600311
[TBL] [Abstract][Full Text] [Related]
12. The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases.
Lin Q; Li M; Fang D; Fang J; Su SB
Int Immunopharmacol; 2011 Oct; 11(10):1422-32. PubMed ID: 21600309
[TBL] [Abstract][Full Text] [Related]
13. How Toll-like receptors signal: what we know and what we don't know.
O'Neill LA
Curr Opin Immunol; 2006 Feb; 18(1):3-9. PubMed ID: 16343886
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applications.
McNeill E; Channon KM; Greaves DR
Clin Sci (Lond); 2010 Mar; 118(11):641-55. PubMed ID: 20210786
[TBL] [Abstract][Full Text] [Related]
15. Innate immunity, macrophage activation, and atherosclerosis.
Yan ZQ; Hansson GK
Immunol Rev; 2007 Oct; 219():187-203. PubMed ID: 17850490
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system.
Netea MG; van der Graaf C; Van der Meer JW; Kullberg BJ
J Leukoc Biol; 2004 May; 75(5):749-55. PubMed ID: 15075354
[TBL] [Abstract][Full Text] [Related]
17. Role of Toll-like receptors in liver health and disease.
Broering R; Lu M; Schlaak JF
Clin Sci (Lond); 2011 Nov; 121(10):415-26. PubMed ID: 21797822
[TBL] [Abstract][Full Text] [Related]
18. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress.
O'Neill LA
Immunol Rev; 2008 Dec; 226():10-8. PubMed ID: 19161412
[TBL] [Abstract][Full Text] [Related]
19. Modulation of toll-like receptors by insulin.
Tilich M; Arora RR
Am J Ther; 2011 Sep; 18(5):e130-7. PubMed ID: 21326087
[TBL] [Abstract][Full Text] [Related]
20. The role of toll-like receptors in chronic inflammation.
Drexler SK; Foxwell BM
Int J Biochem Cell Biol; 2010 Apr; 42(4):506-18. PubMed ID: 19837184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
